Skip to main content
Home U.S.- CHINA | ECONOMIC and SECURITY REVIEW COMMISSION

U.S.-China Economic AND Security Review Commission

  • About Us
    hearings navigation
    About the Commission

    The U.S.-China Economic and Security Review Commission is a legislative branch commission created by the United States Congress in October 2000 with the legislative mandate to monitor, investigate, and submit to Congress an annual report on the national security implications of the bilateral trade and economic relationship between the United States and the People’s Republic of China, and to provide recommendations, where appropriate, to Congress for legislative and administrative action.

    About the Commission
    • Charter
    • Commission Members
    • Commission Staff
    • Job Opportunities
    • Contact Us
  • Annual Reports
  • Recommendations
  • Hearings
  • Research
    research navigation menu drop down
    Research

    The U.S.-China Economic and Security Review Commission is chartered to monitor, investigate, and report to Congress on the national security implications of the bilateral trade and economic relationship between the United States and the People’s Republic of China. The Commission meets its research mission by submitting to Congress an Annual Report, as well as by conducting staff-led reports, contracted research, and more.

    View All Research
    • RESEARCH BY TOPIC
      Censorship and Control RESEARCH BY TOPIC
    • China’s Economy and Resources
    • Compliance with International Rules and Norms
    • Finance and Investment
    • Global Relations and Influence
    • Hong Kong
    • Product Safety
    • Science and Technology
    • Security and Defense
    • Taiwan
    • Trade and Supply Chains
    • FEATURED RESEARCH
      Chinese Companies Listed on Major U.S. Stock Exchanges FEATURED RESEARCH
    • PRC in International Organizations
    • China-Ukraine Timeline

Search

Hearing: China’s Healthcare Sector, Drug Safety, and the U.S.-China Trade in Medical Products (WEBCAST)

Thursday, April 03, 2014

328A Russell Senate Office Building
2 Constitution Ave NE
Washington, DC 20002

Hearing Co-Chairs: Chairman Dennis C. Shea and Vice-Chairman William Reinsch

8:30 – 8:45 am                   Co-chairs’ remarks: Chairman Dennis C. Shea and Vice-Chairman William Reinsch

8:45 – 9:30 am                     Administration Panel

  • Dr. Christopher J. Hickey, Country Director, U.S. Food and Drug Administration, People's Republic of China (Testimony)

9:30 am –9:45 am:              Break

9:45 am – 11:15 am            Panel I: Policy Challenges in China’s Healthcare Sector

  • Dr. Karen Eggleston, Faculty Director, Asia Health Policy Program, Stanford University, Stanford, CA (Testimony)
  • Dr. Yanzhong Huang, Senior Fellow for Global Health Policy, Council on Foreign Relations, New York, NY (Testimony)
  • Xiaoqing Lu Boynton, Director, Albright Stonebridge Group, Washington, DC (Testimony)

11:15 am –11:30 am           Break

11:30 am – 1:00 pm            Panel II: Market Access for U.S. Medical Goods and Services in China

  • Benjamin Shobert, Managing Director, Rubicon Strategy Group, Seattle, WA; Senior Associate, National Bureau of Asian Research, Washington, DC (Testimony)
  • Rod Hunter, Senior Vice President, International Affairs, PhRMA, Washington, DC       
  • Ralph Ives, Executive Vice President, Global Strategy and Analysis, AdvaMed, Washington, DC (Testimony)

1:00 – 2:00 pm                     Lunch break

2:00 pm – 3:30 pm              Panel III: The Safety of Medical Product Imports from China into the United States

  • Allan Coukell, Senior Director, Drugs and Medical Devices, The Pew Charitable Trusts, Washington, DC (Testimony)
  • Charles Bell, Programs Director, Consumers Union, Yonkers, NY (Testimony)
  • Dr. Ginger Zhe Jin, Professor of Economics, University of Maryland, College Park, MD (Testimony)
  • Dr. Roger Bate, Visiting Fellow, American Enterprise Institute, Washington, DC (Written Testimony)

3:30 pm                                  Adjourn

 

Transcript
USCC Hearing Transcript_April 3, 2014.pdf2.7 MB

Subscribe To Our Mailing List

CAPTCHA

U.S.-CHINA

U.S.-China Economic and
Security Review Commission

444 North Capitol Street NW, Suite 602
Washington, DC 20001

202-624-1407linkedintwitter

Footer menu

  • Contact Us
  • All Announcements
  • Privacy
  • Accessibility